Liver-targeting of interferon-alpha with tissue-specific domain antibodies.

Interferon alpha (IFNα) is used for the treatment of hepatitis C infection and whilst efficacious it is associated with multiple adverse events including reduced leukocyte, erythrocyte, and platelet counts, fatigue, and depression. These events are most likely caused by systemic exposure to interfer...

Cijeli opis

Bibliografski detalji

Glavni autori:	Edward Coulstock, Jane Sosabowski, Milan Ovečka, Rob Prince, Laura Goodall, Clare Mudd, Armin Sepp, Marie Davies, Julie Foster, Jerome Burnet, Gráinne Dunlevy, Adam Walker
Format:	Artigo
Jezik:	Inglês
Izdano:	Public Library of Science (PLoS) 2013-01-01
Serija:	PLoS ONE
Online pristup:	http://europepmc.org/articles/PMC3581439?pdf=render
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!